Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (Novartis)

脑膜炎双球菌(A、C、Y和W-135群)寡糖白喉CRM197结合疫苗（诺华）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (Novartis)
Drug Alias NameMultivalent ACWY vaccine candidateMCV4 vaccineMenACWY, NovartisMenveoMenjugatge +[7] 
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Global Approved IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2010/03/15
Country/TerritoryCanadaUnited StatesPuerto Rico +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSanofi PasteurGsk Vaccines Srl
Inactive CompaniesGlaxosmithkline PlcNovartis Pharma AgNovartis Vaccines
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH08
Related LinksN/A